# Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections

> **NCT02492594** · — · COMPLETED · sponsor: **St. Anna Kinderkrebsforschung** · enrollment: 244 (actual)

## Conditions studied

- Systemic Mycosis

## Interventions

- **OTHER:** Peripheral blood sampling

## Key facts

- **NCT ID:** NCT02492594
- **Lead sponsor:** St. Anna Kinderkrebsforschung
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02492594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02492594, "Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02492594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*